RxDoctor Payments Data

James Peabody, MD

Urology · Detroit, MINPI 1396805164

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (43.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 82.3% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $5,473 and has fallen 95.8% since, to $232 in 2025.

$8,979in general payments, 2019–2025

Across 46 payments — averaging $195.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$7K
  • EDAP Technomed Inc$291
  • Procept Biorobotics Corporation$205
  • Ambu Inc.$197
  • Coloplast$179
  • Palette Life Sciences, Inc.$151
  • plus $566 from 7 others
$2,094,447in research payments, 2019–2025

Across 109 payments — averaging $19,215 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$2M
  • Genentech, Inc.$62K

What the payments were for

  • Travel & lodging$3,25236%
  • Food & beverage$1,84221%
  • Education$3,88643%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,979 in reported general payments places this provider in the 75th percentile of 400 urology providers in Michigan.

See all urology providers in Michigan

Medicare billing

Part B allowed, 2024
$72,133
Medicare patients
145
Services billed
288

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron17$17,177
Tamsulosin Hcl83$1,988
Finasteride15$289
Ketorolac Tromethamine12$146
Methocarbamol18$41
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim26$24

Paid to pharmacies, not to this prescriber.

Other urology in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →